x
0

Alexion Pharmaceuticals Inc (ALXN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Alexion's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
101.08 -3.56    -3.40%
24/05 - Closed. Currency in USD ( Disclaimer )
After Hours
101.08
0.00
0.00%
24/05
Type: Equity
Market: United States
ISIN: US0153511094 
CUSIP: 015351109
  • Volume: 9,759,689
  • Bid/Ask: 101.00 / 101.65
  • Day's Range: 98.63 - 105.00
Start Trading
Alexion 101.08 -3.56 -3.40%

ALXN Overview

 
Information about the Alexion Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close104.64
Day's Range98.63 - 105
Revenue3.95B
Open104.5
52 wk Range98.63 - 157.02
EPS2.11
Volume9,759,689
Market Cap23.5B
Dividend (Yield)0 (N/A)
Average Vol. (3m)1,946,058
P/E Ratio49.69
Beta1.5
1-Year Change - 31.08%
Shares Outstanding224,556,542
Next Earnings DateJul 26, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Sell Sell Strong Sell Sell
Technical Indicators Strong Buy Strong Buy Strong Sell Strong Sell Strong Sell
Summary Strong Buy Neutral Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 30 Current
Bullish doji Star 5H Current
Completed Patterns
Three Outside Down 1W 1 May 14, 2017
Bullish Engulfing 30 1 May 24, 2017 03:00PM
Engulfing Bearish 1W 2 May 07, 2017

Alexion Pharmaceuticals Inc News & Analysis

News


Alexion Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 101.08 101.00 101.65 9,759,689 -3.40% USD 24/05  
  Xetra 90.90 89.19 90.31 0 0.00% EUR 24/05  
  Munich 92.14 90.90 92.14 0 -1.68% EUR 06:05:00  
  TradeGate 92.18 91.91 92.84 100 +1.86% EUR 06:00:00  
  Berlin 91.06 91.15 92.36 0 -2.05% EUR 06:08:00  
  Stuttgart 91.50 91.50 93.50 0 +1.18% EUR 06:03:00  
  Frankfurt 90.80 90.90 92.14 0 +1.39% EUR 06:01:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Sintex Industries 104.10 34.00 16.25 -77.75 -74.69% 149.26M 07:05:00  
  Apple 153.34 154.17 152.67 -0.46 -0.30% 19.22M 24/05  
  ICICI Bank 312.80 314.00 306.00 +6.10 +1.99% 10.62M 07:05:00  
  Tata Motors 475.20 478.85 464.70 +5.65 +1.20% 7.63M 07:05:00  
  Alphabet 977.61 978.12 971.63 +7.06 +0.73% 1.14M 24/05  
  Facebook 150.04 150.23 148.42 +1.97 +1.33% 17.94M 24/05  
  Bharat Financial 712.70 722.00 692.60 +42.25 +6.30% 3.28M 07:05:00  
  Lupin 1,139.15 1,180.00 1,133.50 -89.35 -7.27% 4.20M 07:05:00  
  Tesla 310.22 311.00 305.40 +6.36 +2.09% 5.04M 24/05  
  Tata Consultancy 2,602.35 2,611.00 2,568.00 +43.20 +1.69% 1.11M 07:05:00  

Alexion Pharmaceuticals Inc Company Profile

IndustryMajor Drugs
SectorHealthcare
Employees

3121

Equity Type

ORD

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
No Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest ALXN Comments

Charles Patterson
Charles Patterson 13 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do they do?
Joel Hanson
Joel Hanson Dec 12, 2016 3:27PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TP of $171.75 by 22 analyst, 18 buy, 4 hold. ALXN had typical mass hysteria to CEO/CFO resigning. Get in now that these loons have dropped all their shares.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.